Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$7.01 - $11.37 $3.74 Million - $6.06 Million
-532,847 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$13.08 - $49.6 $2.42 Million - $9.19 Million
185,185 Added 53.27%
532,847 $8.55 Million
Q4 2020

Feb 16, 2021

SELL
$36.36 - $52.71 $25.3 Million - $36.6 Million
-694,798 Reduced 66.65%
347,662 $16.1 Million
Q3 2020

Nov 13, 2020

BUY
$22.61 - $38.9 $5.48 Million - $9.43 Million
242,460 Added 30.31%
1,042,460 $36.7 Million
Q2 2020

Nov 13, 2020

BUY
$13.87 - $28.44 $11.1 Million - $22.8 Million
800,000 New
800,000 $19.5 Million

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.